Valeurs | |||||
Le rangement donne un aperçu de toutes les valeurs mobilières classées de manière alphabétique ou selon les indices. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Nom | Code | Analysis date | Cours de clôture | +/- % |
Qlife Holding | QLIFE | 28. mar 2024 | 0.01 | -5.22 |
Qliro | QLIRO | 28. mar 2024 | 23.60 | +1.29 |
Qlosr Group B | QLOSRB | 28. mar 2024 | 1.58 | 0.00 |
Qlucore | QCORE | 28. mar 2024 | 8.60 | +2.38 |
Quartiers Properties | QUART | 28. mar 2024 | 9.06 | -1.95 |
Quartiers Properties Pref | QUARTPREF | 28. mar 2024 | 10.00 | -1.96 |
Quartiers Properties PREF | QARTMTFPREF | 28. mar 2024 | 10.00 | +0.40 |
QuiaPEG Pharmaceuticals Holding AB | QUIA | 28. mar 2024 | 0.06 | 0.00 |
Quickbit | QBIT | 28. mar 2024 | 1.34 | -1.04 |
Railcare Group | RAIL | 28. mar 2024 | 25.20 | +0.40 |
Railway Metrics and Dynamics Sweden AB | RMDX | 28. mar 2024 | 2.20 | 0.00 |
Raketech | RAKE | 28. mar 2024 | 16.32 | -0.24 |
Rana Gruber ASA | RANAO | 28. mar 2024 | 77.30 | 0.00 |
RanLOS | RLOSB | 28. mar 2024 | 7.07 | 0.00 |
Ranplan Group | RPLAN | 28. mar 2024 | 1.17 | 0.00 |
Ratos A | RATOA | 28. mar 2024 | 37.35 | +0.40 |
Ratos B | RATOB | 28. mar 2024 | 35.18 | +2.39 |
RaySearch Laboratories B | RAYB | 28. mar 2024 | 115.00 | +0.52 |
Raytelligence | RAYTL | 28. mar 2024 | 0.00 | 0.00 |
Readly International | READ | 28. mar 2024 | 14.34 | +0.28 |
RealFiction | REALFI | 28. mar 2024 | 16.05 | 0.00 |
Reato Group AB | REATO | 28. mar 2024 | 1.33 | 0.00 |
Recyctec B | RECYB | 28. mar 2024 | 0.43 | -10.32 |
Rederi Gotland AB | GOTLA | 28. mar 2024 | 2 140.00 | -6.96 |
Rederi Gotland AB. ser. B | GOTLB | 28. mar 2024 | 2 200.00 | 0.00 |
Redsense Medical | REDS | 28. mar 2024 | 5.68 | -0.70 |
Redwood Pharma | REDW | 28. mar 2024 | 1.19 | -3.27 |
Refine Group | REFINE | 28. mar 2024 | 1.61 | -7.76 |
Rejlers B | REJLB | 28. mar 2024 | 143.50 | +0.35 |
Renewable Ventures Nordic | RVN | 28. mar 2024 | 6.50 | 0.00 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.